Annual Net Income
$672.64 M
+$110.54 M+19.66%
March 31, 2024
Summary
- As of February 24, 2025, RDY annual net profit is $672.64 million, with the most recent change of +$110.54 million (+19.66%) on March 31, 2024.
- During the last 3 years, RDY annual net income has risen by +$440.86 million (+190.21%).
- RDY annual net income is now at all-time high.
Performance
RDY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
$167.29 M
+$17.45 M+11.65%
December 31, 2024
Summary
- As of February 24, 2025, RDY quarterly net profit is $167.29 million, with the most recent change of +$17.45 million (+11.65%) on December 31, 2024.
- Over the past year, RDY quarterly net income has increased by +$1.69 million (+1.02%).
- RDY quarterly net income is now -6.54% below its all-time high of $178.99 million, reached on September 30, 2023.
Performance
RDY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$474.51 M
+$1.69 M+0.36%
December 31, 2024
Summary
- As of February 24, 2025, RDY TTM net profit is $474.51 million, with the most recent change of +$1.69 million (+0.36%) on December 31, 2024.
- Over the past year, RDY TTM net income has dropped by -$157.57 million (-24.93%).
- RDY TTM net income is now -29.46% below its all-time high of $672.69 million, reached on March 31, 2024.
Performance
RDY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RDY Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +19.7% | +1.0% | -24.9% |
3 y3 years | +190.2% | +1337.9% | +49.6% |
5 y5 years | +150.3% | +1337.9% | +49.6% |
RDY Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +190.2% | -6.5% | +1337.9% | -29.5% | +49.6% |
5 y | 5-year | at high | +190.2% | -6.5% | +309.4% | -29.5% | +133.0% |
alltime | all time | at high | +697.3% | -6.5% | +184.9% | -29.5% | +321.8% |
Dr Reddys Laboratories Limited Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | $167.29 M(+11.6%) | $474.51 M(+0.4%) |
Sep 2024 | - | $149.84 M(-4.8%) | $472.83 M(-29.7%) |
Mar 2024 | $672.64 M(+19.7%) | $157.38 M(-5.0%) | $672.69 M(+6.4%) |
Dec 2023 | - | $165.60 M(-7.5%) | $632.08 M(+2.2%) |
Sep 2023 | - | $178.99 M(+4.8%) | $618.35 M(+6.8%) |
Jun 2023 | - | $170.71 M(+46.2%) | $578.84 M(+3.0%) |
Mar 2023 | $562.10 M(+77.7%) | $116.77 M(-23.1%) | $562.06 M(+23.0%) |
Dec 2022 | - | $151.87 M(+8.9%) | $456.92 M(+14.4%) |
Sep 2022 | - | $139.49 M(-9.4%) | $399.30 M(+1.4%) |
Jun 2022 | - | $153.93 M(+1223.1%) | $393.69 M(+24.1%) |
Mar 2022 | $316.38 M(+36.5%) | $11.63 M(-87.7%) | $317.16 M(-10.7%) |
Dec 2021 | - | $94.25 M(-29.6%) | $355.23 M(+34.7%) |
Sep 2021 | - | $133.88 M(+73.0%) | $263.66 M(+13.6%) |
Jun 2021 | - | $77.40 M(+55.7%) | $232.05 M(+0.6%) |
Mar 2021 | $231.78 M(-15.6%) | $49.70 M(+1756.5%) | $230.68 M(-19.4%) |
Dec 2020 | - | $2.68 M(-97.4%) | $286.22 M(+40.6%) |
Sep 2020 | - | $102.27 M(+34.5%) | $203.64 M(-20.5%) |
Jun 2020 | - | $76.04 M(-27.7%) | $256.27 M(-6.9%) |
Mar 2020 | $274.56 M(+2.2%) | $105.23 M(-231.7%) | $275.36 M(+18.8%) |
Dec 2019 | - | -$79.90 M(-151.6%) | $231.73 M(-38.8%) |
Sep 2019 | - | $154.91 M(+62.8%) | $378.88 M(+28.1%) |
Jun 2019 | - | $95.13 M(+54.4%) | $295.78 M(+10.1%) |
Mar 2019 | $268.68 M(+76.6%) | $61.60 M(-8.4%) | $268.70 M(+5.8%) |
Dec 2018 | - | $67.25 M(-6.4%) | $254.06 M(+6.5%) |
Sep 2018 | - | $71.81 M(+5.5%) | $238.50 M(+13.0%) |
Jun 2018 | - | $68.04 M(+44.9%) | $211.00 M(+38.7%) |
Mar 2018 | $152.10 M(-15.3%) | $46.96 M(-9.1%) | $152.13 M(+0.2%) |
Dec 2017 | - | $51.69 M(+16.6%) | $151.82 M(-10.6%) |
Sep 2017 | - | $44.32 M(+383.6%) | $169.88 M(+0.1%) |
Jun 2017 | - | $9.16 M(-80.4%) | $169.63 M(-5.4%) |
Mar 2017 | $179.53 M(-41.3%) | $46.66 M(-33.1%) | $179.35 M(+24.8%) |
Dec 2016 | - | $69.74 M(+58.3%) | $143.74 M(-11.2%) |
Sep 2016 | - | $44.07 M(+133.5%) | $161.86 M(-29.3%) |
Jun 2016 | - | $18.88 M(+70.8%) | $228.97 M(-25.8%) |
Mar 2016 | $305.93 M(-15.7%) | $11.05 M(-87.4%) | $308.77 M(-19.0%) |
Dec 2015 | - | $87.86 M(-21.0%) | $381.08 M(-1.3%) |
Sep 2015 | - | $111.19 M(+12.7%) | $385.96 M(+4.5%) |
Jun 2015 | - | $98.68 M(+18.4%) | $369.47 M(+1.8%) |
Mar 2015 | $362.83 M(+1.6%) | $83.36 M(-10.1%) | $362.82 M(+1.5%) |
Dec 2014 | - | $92.74 M(-2.1%) | $357.39 M(-1.9%) |
Sep 2014 | - | $94.70 M(+2.9%) | $364.38 M(-4.3%) |
Jun 2014 | - | $92.02 M(+18.1%) | $380.85 M(+7.7%) |
Mar 2014 | $357.06 M(+15.7%) | $77.93 M(-21.9%) | $353.67 M(-7.2%) |
Dec 2013 | - | $99.73 M(-10.3%) | $381.09 M(+8.5%) |
Sep 2013 | - | $111.17 M(+71.5%) | $351.19 M(+12.9%) |
Jun 2013 | - | $64.83 M(-38.5%) | $311.13 M(+0.8%) |
Mar 2013 | $308.68 M | $105.36 M(+50.9%) | $308.62 M(+20.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | - | $69.82 M(-1.8%) | $255.46 M(-10.9%) |
Sep 2012 | - | $71.11 M(+14.1%) | $286.75 M(+1.3%) |
Jun 2012 | - | $62.33 M(+19.4%) | $283.00 M(+1.3%) |
Mar 2012 | $298.89 M(+23.3%) | $52.20 M(-48.4%) | $279.48 M(-7.2%) |
Dec 2011 | - | $101.11 M(+50.1%) | $301.28 M(+15.4%) |
Sep 2011 | - | $67.36 M(+14.6%) | $261.17 M(+2.2%) |
Jun 2011 | - | $58.81 M(-20.5%) | $255.56 M(+5.3%) |
Mar 2011 | $242.50 M(+975.5%) | $74.00 M(+21.3%) | $242.72 M(+18.4%) |
Dec 2010 | - | $61.01 M(-1.2%) | $205.04 M(+541.0%) |
Sep 2010 | - | $61.76 M(+34.4%) | $31.99 M(+110.8%) |
Jun 2010 | - | $45.96 M(+26.6%) | $15.18 M(-21.9%) |
Mar 2010 | $22.55 M(-120.0%) | $36.31 M(-132.4%) | $19.43 M(-109.1%) |
Dec 2009 | - | -$112.04 M(-349.3%) | -$213.97 M(+314.0%) |
Sep 2009 | - | $44.94 M(-10.5%) | -$51.69 M(-29.0%) |
Jun 2009 | - | $50.21 M(-125.5%) | -$72.77 M(-24.4%) |
Mar 2009 | -$112.61 M(-217.3%) | -$197.08 M(-492.3%) | -$96.31 M(-177.6%) |
Dec 2008 | - | $50.24 M(+110.6%) | $124.09 M(+187.6%) |
Sep 2008 | - | $23.86 M(-10.5%) | $43.15 M(-42.4%) |
Jun 2008 | - | $26.67 M(+14.4%) | $74.90 M(-14.1%) |
Mar 2008 | $95.97 M(-53.7%) | $23.32 M(-175.9%) | $87.19 M(-36.8%) |
Dec 2007 | - | -$30.70 M(-155.2%) | $137.99 M(-34.5%) |
Sep 2007 | - | $55.61 M(+42.8%) | $210.76 M(-2.2%) |
Jun 2007 | - | $38.96 M(-47.4%) | $215.45 M(+3.9%) |
Mar 2007 | $207.49 M(+460.6%) | $74.12 M(+76.2%) | $207.39 M(+62.0%) |
Dec 2006 | - | $42.06 M(-30.3%) | $128.04 M(+28.2%) |
Sep 2006 | - | $60.30 M(+95.2%) | $99.84 M(+66.4%) |
Jun 2006 | - | $30.90 M(-690.9%) | $59.99 M(+61.8%) |
Mar 2006 | $37.01 M(+684.4%) | -$5.23 M(-137.7%) | $37.07 M(+17.0%) |
Dec 2005 | - | $13.86 M(-32.2%) | $31.70 M(+69.9%) |
Sep 2005 | - | $20.45 M(+156.3%) | $18.66 M(+97.8%) |
Jun 2005 | - | $7.98 M(-175.3%) | $9.43 M(+77.2%) |
Mar 2005 | $4.72 M(-91.3%) | -$10.60 M(-1386.2%) | $5.32 M(-72.9%) |
Dec 2004 | - | $824.30 K(-92.7%) | $19.64 M(-38.3%) |
Sep 2004 | - | $11.23 M(+189.8%) | $31.83 M(-22.1%) |
Jun 2004 | - | $3.87 M(+4.4%) | $40.86 M(-24.1%) |
Mar 2004 | $53.99 M(-25.8%) | $3.71 M(-71.5%) | $53.86 M(-15.9%) |
Dec 2003 | - | $13.02 M(-35.7%) | $64.02 M(-2.1%) |
Sep 2003 | - | $20.26 M(+20.1%) | $65.40 M(+0.9%) |
Jun 2003 | - | $16.87 M(+21.6%) | $64.79 M(-10.9%) |
Mar 2003 | $72.73 M(-29.3%) | $13.87 M(-3.7%) | $72.70 M(-9.5%) |
Dec 2002 | - | $14.40 M(-26.7%) | $80.36 M(-13.8%) |
Sep 2002 | - | $19.65 M(-20.7%) | $93.26 M(-21.1%) |
Jun 2002 | - | $24.78 M(+15.1%) | $118.27 M(+15.0%) |
Mar 2002 | $102.91 M(+536.5%) | $21.53 M(-21.1%) | $102.84 M(+26.5%) |
Dec 2001 | - | $27.30 M(-38.9%) | $81.30 M(+50.5%) |
Sep 2001 | - | $44.66 M(+377.9%) | $54.01 M(+477.9%) |
Jun 2001 | - | $9.35 M | $9.35 M |
Mar 2001 | $16.17 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual net profit?
- What is the all time high annual net income for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual net income year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly net profit?
- What is the all time high quarterly net income for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly net income year-on-year change?
- What is Dr Reddys Laboratories Limited TTM net profit?
- What is the all time high TTM net income for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM net income year-on-year change?
What is Dr Reddys Laboratories Limited annual net profit?
The current annual net income of RDY is $672.64 M
What is the all time high annual net income for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual net profit is $672.64 M
What is Dr Reddys Laboratories Limited annual net income year-on-year change?
Over the past year, RDY annual net profit has changed by +$110.54 M (+19.66%)
What is Dr Reddys Laboratories Limited quarterly net profit?
The current quarterly net income of RDY is $167.29 M
What is the all time high quarterly net income for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly net profit is $178.99 M
What is Dr Reddys Laboratories Limited quarterly net income year-on-year change?
Over the past year, RDY quarterly net profit has changed by +$1.69 M (+1.02%)
What is Dr Reddys Laboratories Limited TTM net profit?
The current TTM net income of RDY is $474.51 M
What is the all time high TTM net income for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM net profit is $672.69 M
What is Dr Reddys Laboratories Limited TTM net income year-on-year change?
Over the past year, RDY TTM net profit has changed by -$157.57 M (-24.93%)